S'abonner

IL-10–overexpressing B cells regulate innate and adaptive immune responses - 05/03/15

Doi : 10.1016/j.jaci.2014.07.041 
Barbara Stanic, PhD, Willem van de Veen, PhD, Oliver F. Wirz, MSc, Beate Rückert, Sci Tec, Hideaki Morita, MD, PhD, Stefan Söllner, Sci Tec, Cezmi A. Akdis, MD, Mübeccel Akdis, MD, PhD
 Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos, Switzerland 

Corresponding author: Mübeccel Akdis, MD, PhD, Swiss Institute of Allergy and Asthma Research (SIAF), Obere Strasse 22, CH-7270, Davos, Switzerland.

Abstract

Background

Distinct human IL-10–producing B-cell subsets with immunoregulatory properties have been described. However, the broader spectrum of their direct cellular targets and suppressive mechanisms has not been extensively studied, particularly in relation to direct and indirect IL-10–mediated functions.

Objective

The aim of the study was to investigate the effects of IL-10 overexpression on the phenotype and immunoregulatory capacity of B cells.

Methods

Primary human B cells were transfected with hIL-10, and IL-10–overexpressing B cells were characterized for cytokine and immunoglobulin production by means of specific ELISA and bead-based assays. Antigen presentation, costimulation capacity, and transcription factor signatures were analyzed by means of flow cytometry and quantitative RT-PCR. Effects of IL-10–overexpresing B cells on Toll-like receptor–triggered cytokine release from PBMCs, LPS-triggered maturation of monocyte-derived dendritic cells, and tetanus toxoid–induced PBMC proliferation were assessed in autologous cocultures.

Results

IL-10–overexpressing B cells acquired a prominent immunoregulatory profile comprising upregulation of suppressor of cytokine signaling 3 (SOCS3), glycoprotein A repetitions predominant (GARP), the IL-2 receptor α chain (CD25), and programmed cell death 1 ligand 1 (PD-L1). Concurrently, their secretion profile was characterized by a significant reduction in levels of proinflammatory cytokines (TNF-α, IL-8, and macrophage inflammatory protein 1α) and augmented production of anti-inflammatory IL-1 receptor antagonist and vascular endothelial growth factor. Furthermore, IL-10 overexpression was associated with a decrease in costimulatory potential. IL-10–overexpressing B cells secreted less IgE and potently suppressed proinflammatory cytokines in PBMCs, maturation of monocyte-derived dendritic cells (rendering their profile to regulatory phenotype), and antigen-specific proliferation in vitro.

Conclusion

Our data demonstrate an essential role for IL-10 in inducing an immunoregulatory phenotype in B cells that exerts substantial anti-inflammatory and immunosuppressive functions.

Le texte complet de cet article est disponible en PDF.

Key words : IL-10 overexpression, regulatory B cells, immune regulation, anti-inflammatory effects, immunoregulatory capacity

Abbreviations used : APC, BLIMP-1, Br1, DC, FITC, GARP, G-CSF, IL-1Ra, IRF-4, MDDC, MIP, PD-L1, PE, SOCS, TLR, TLR-L, TT, VEGF, XBP-1


Plan


 Supported by the Swiss National Science Foundation (grant no. 320030-125249/1, 32-188226, 320030-140772), the Christine Kühne-Center for Allergy Research and Education (CK-CARE), and the European Commission's Seventh Framework Programme (grant agreement no. 261357 MeDALL).
 Disclosure of potential conflict of interest: C. A. Akdis has consultant arrangements with Actellion, Aventis, Stallergenes, Allergopharma, and Circacia; is employed by the Swiss Institute of Allergy and Asthma Research, University of Zurich; and has received research support from Novartis, PREDICTA: European Commission's Seventh Framework, the Swiss National Science Foundation, MeDALL: European Commission's Seventh Framework, and the Christine Kühne-Center for Allergy Research and Education. M. Akdis has received research support from the Swiss National Science Foundation and the European Commission's Seventh Framework Programme. The rest of the authors declare that they have no relevant conflicts of interest.


© 2014  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 135 - N° 3

P. 771 - mars 2015 Retour au numéro
Article précédent Article précédent
  • IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome
  • Omar Niss, Allyson Sholl, Jack J. Bleesing, David A. Hildeman
| Article suivant Article suivant
  • Thymic stromal lymphopoietin signaling in CD4+ T cells is required for TH2 memory
  • Qun Wang, Jianguang Du, Jingjing Zhu, Xiaowei Yang, Baohua Zhou

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.